Thomas A. Raffin's Net Worth
$114 Million
Who is Thomas A. Raffin?
Thomas A. Raffin has an estimated net worth of $114 Million. This is based on reported shares across multiple companies, which include LDR HOLDING CORP, Akoya Biosciences, Inc., and LUMOS PHARMA, INC..
SEC CIK
Thomas A. Raffin's CIK is 0001512119
Past Insider Trading and Trends
2013 was Thomas A. Raffin's most active year for acquiring shares with 13 total transactions. Thomas A. Raffin's most active month to acquire stocks was the month of April. 2014 was Thomas A. Raffin's most active year for disposing of shares, totalling 45 transactions. Thomas A. Raffin's most active month to dispose stocks was the month of January. 2023 saw Thomas A. Raffin paying a total of $10,100,000.00 for 2,079,667 shares, this is the most they've acquired in one year. In 2015 Thomas A. Raffin cashed out on 486,922 shares for a total of $18,062,286.88, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
LDR HOLDING CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -7.97% | -222.77K |
$38.00 | -$8,466,046.55 | 2.57M |
Feb 19 - Feb 23
| |||
Form 4
| -7.97% | -222.77K |
$38.00 | -$8,466,046.55 | 2.57M |
Feb 19 - Feb 23
| |||
Form 4
| -2.78% | -80.00K |
$33.15 | -$2,651,851.76 | 2.79M |
Oct 17 - Oct 21
| |||
Form 4
| -0.97% | -28.07K |
$31.49 | -$884,187.37 | 2.87M |
Sep 29 - Oct 1
| |||
Form 4
| -6.45% | -200.00K |
$31.22 | -$6,243,650.00 | 2.9M |
Sep 24 - Sep 26
| |||
Form 4
| +841.74% | 3.1M |
$15.00 | $107,625.00 | 3.47M |
Oct 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akoya Biosciences, Inc. (AKYA) Snapshot price: $6.015
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
| +12.71% | 2.02M |
$5.00 | $10,100,000.00 | 17.91M |
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LUMOS PHARMA, INC. (LUMO) Snapshot price: $3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
| +13.93% | 1.15K |
$8.46 | $9,729.00 | 9.41K |
Aug 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
| +4.65% | 367 |
—
|
—
| 8.26K |
May 20
| |||
Form 4
| +9.87% | 709 |
—
|
—
| 7.89K |
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
| +3.13% | 1.96K |
—
|
—
| 64.62K |
Apr 30
| |||
Form 4
|
—
|
0
|
$29.70 | -$1,031,069.14 | 62.66K |
Scheduled
|
Apr 7
| ||
Form 4
| +4.93% | 2.94K |
—
|
—
| 62.66K |
May 1
| |||
Form 4
| +5.29% | 3K |
—
|
—
| 59.72K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
| +19.10% | 9.1K |
—
|
—
| 56.72K |
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||